On this page
A name is the beginning of a comparison
When two listings both say TB-500, it is tempting to put them in the same column and choose the lower price. Start one step earlier. Ask each provider to state the ingredient it would actually prescribe, the formulation, the intended route and whether the offer contains one ingredient or a combination. Copy the answer in the provider's own words. A label that sounds more familiar is not necessarily a more complete answer, and a confident explanation does not replace a precise product description.
Keep the fragment separate from the full-length peptide
The FDA's TB-500 briefing discusses the LKKTETQ fragment and explains why results involving other forms need careful interpretation. That is a useful reason to avoid silently treating thymosin beta-4 and every TB-500 listing as the same product. If a provider cites research, ask which studied ingredient matches its offering. You should not need to reconstruct this from an influencer's glossary. An unclear answer is a missing comparison field, not an invitation to supply the most reassuring interpretation yourself.
Separate a consultation from a product order
Read what the first payment buys. Is it an appointment, a clinician's assessment, membership access or an initial service package? Write that down separately from any later prescription and dispensing charges. A consultation should not be presented as a promise that a particular product will be prescribed. If the landing page and checkout describe different things, pause and request a written explanation before paying. Clear service language makes a comparison more useful even when neither option can yet be judged on clinical benefit. The Pepti ingredient review preserves the TB-500 wording while leaving the exact matching questions open.
Build a like-for-like price column
For each offer, use the same time window and the same set of charges. Include the initial assessment, any required follow-up, mandatory testing if applicable, shipping and recurring membership. Mark a charge unknown if the provider has not supplied it. Do not turn the lowest visible starting price into an estimated monthly total by guessing the missing components. A fully explained higher total may be easier to evaluate than an attractive first payment attached to an undefined commitment. Use the provider comparison board to keep the published identity, payment and pharmacy fields separate.
Ask who handles the handoffs
A provider brand, the clinician responsible for an assessment and a dispensing pharmacy may have different responsibilities. Ask how you learn who is involved and where questions go before and after payment. If a service says it operates in your state, ask about the specific offering rather than assuming every product in its catalog follows the same rules. These questions are about a transparent care process. They do not establish that a product is suitable for you, or that a particular formulation has proven benefits.
Finish with a short written record
Before choosing, keep four lines: the exact proposed ingredient, what your payment covers, what remains uncertain and how cancellation works. Add the date and a copy of the terms you relied on. Avoid filling the uncertainty line with general promises about recovery or a list of studies that use a different ingredient. A useful next conversation starts with a specific unanswered question. If the ingredient still cannot be identified clearly, more discount codes will not make the comparison ready. For example, one listing might quote only a consultation while another describes a consultation plus continuing support. They are not yet a price comparison of the same service. Request the missing breakdown before calculating a saving. Likewise, a clearly named ingredient on one page and a broad product nickname on another belong in different confidence columns until the second description becomes explicit. A precise label makes the rest of the discussion possible.
Sources & further reading
Primary research, provider documents and policy sources used in this article. Sources do not endorse this publication.
Source review: 2026-10-28. Provider terms and policy documents can change.